• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国门诊护理环境中成年多发性硬化症患者伴发抑郁症的治疗情况

Depression Treatment among Adults with Multiple Sclerosis and Depression in Ambulatory Care Settings in the United States.

作者信息

Bhattacharjee Sandipan, Goldstone Lisa, Ip Queeny, Warholak Terri

机构信息

Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, Tucson, AZ, USA.

出版信息

Mult Scler Int. 2017;2017:3175358. doi: 10.1155/2017/3175358. Epub 2017 Apr 27.

DOI:10.1155/2017/3175358
PMID:28536657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5425847/
Abstract

. There is little information regarding depression treatment patterns among adults with MS and depression in ambulatory settings at national level in the United States (US). . The objectives of this study were to identify patterns and predictors of depression treatment in ambulatory settings in US among adults with MS and depression. . A cross-sectional study was conducted by pooling multiple years (2005-2011) of National Ambulatory Medical Care Survey and the outpatient department of the National Hospital Ambulatory Medical Care Survey data. The final study sample was comprised of ambulatory visits among adults with MS and depression. Dependent variable of this study was pharmacological treatment for depression with or without psychotherapy. Predictors of depression treatment were determined by conducting multivariable logistic regression. . Out of all ambulatory visits involving MS diagnosis, 20.59% also involved a depression diagnosis. Depression treatment was observed in 57.25% of the study population. Fluoxetine was the most prescribed individual antidepressant. Age and total number of chronic diseases were significant predictors of depression treatment. . Approximately six out of ten ambulatory visits involving MS and depression recorded some form of depression treatment. Future longitudinal studies should examine health outcomes associated with depression treatment in this population.

摘要

在美国全国范围内,关于患有多发性硬化症(MS)的成年人在门诊环境中抑郁症治疗模式的信息很少。本研究的目的是确定美国患有MS和抑郁症的成年人在门诊环境中抑郁症治疗的模式和预测因素。通过汇总多年(2005 - 2011年)的国家门诊医疗调查和国家医院门诊医疗调查门诊部门的数据进行了一项横断面研究。最终的研究样本包括患有MS和抑郁症的成年人的门诊就诊情况。本研究的因变量是接受或未接受心理治疗的抑郁症药物治疗。通过进行多变量逻辑回归确定抑郁症治疗的预测因素。在所有涉及MS诊断的门诊就诊中,20.59%也涉及抑郁症诊断。在57.25%的研究人群中观察到了抑郁症治疗。氟西汀是最常开具的单一抗抑郁药。年龄和慢性病总数是抑郁症治疗的重要预测因素。大约十分之六涉及MS和抑郁症的门诊就诊记录了某种形式的抑郁症治疗。未来的纵向研究应检查该人群中与抑郁症治疗相关的健康结果。

相似文献

1
Depression Treatment among Adults with Multiple Sclerosis and Depression in Ambulatory Care Settings in the United States.美国门诊护理环境中成年多发性硬化症患者伴发抑郁症的治疗情况
Mult Scler Int. 2017;2017:3175358. doi: 10.1155/2017/3175358. Epub 2017 Apr 27.
2
Patterns and Predictors of Depression Treatment among Stroke Survivors with Depression in Ambulatory Settings in the United States.美国门诊环境中患有抑郁症的中风幸存者的抑郁症治疗模式及预测因素
J Stroke Cerebrovasc Dis. 2018 Mar;27(3):563-567. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.047. Epub 2017 Oct 31.
3
Patterns and predictors of depression treatment among adults with chronic kidney disease and depression in ambulatory care settings in the United States.美国门诊护理环境中患有慢性肾病和抑郁症的成年人抑郁症治疗模式及预测因素。
Int Urol Nephrol. 2019 Feb;51(2):303-309. doi: 10.1007/s11255-018-2034-3. Epub 2018 Dec 4.
4
Patterns and Predictors of Depression Treatment among Older Adults with Parkinson's Disease and Depression in Ambulatory Care Settings in the United States.美国门诊护理环境中患有帕金森病和抑郁症的老年人抑郁症治疗模式及预测因素
Parkinsons Dis. 2018 Mar 1;2018:3402983. doi: 10.1155/2018/3402983. eCollection 2018.
5
Patterns and predictors of antidepressant prescribing among adults with cancer and depression in ambulatory care settings in the United States.美国门诊环境中癌症合并抑郁的成年患者抗抑郁药处方的模式和预测因素。
J Oncol Pharm Pract. 2024 Jan;30(1):112-119. doi: 10.1177/10781552231168598. Epub 2023 Apr 6.
6
Depression Screening Patterns, Predictors, and Trends Among Adults Without a Depression Diagnosis in Ambulatory Settings in the United States.美国门诊环境中未被诊断为抑郁症的成年人的抑郁筛查模式、预测因素和趋势。
Psychiatr Serv. 2018 Oct 1;69(10):1098-1100. doi: 10.1176/appi.ps.201700439. Epub 2018 Jul 9.
7
Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.1996 - 2003年美国心理健康障碍患者在成人门诊护理就诊时的抗精神病药物使用情况:全国估计数及相关因素
Clin Ther. 2007 Apr;29(4):723-41. doi: 10.1016/j.clinthera.2007.04.017.
8
When depression is diagnosed, older adults are as likely as younger adults to be prescribed pharmacotherapy and psychotherapy.当被诊断出患有抑郁症时,老年人和年轻人一样有可能接受药物治疗和心理治疗。
Gen Hosp Psychiatry. 2016 Nov-Dec;43:6-11. doi: 10.1016/j.genhosppsych.2016.08.002. Epub 2016 Aug 16.
9
Diplopia-Related Ambulatory and Emergency Department Visits in the United States, 2003-2012.美国 2003-2012 年与复视相关的门诊和急诊科就诊情况。
JAMA Ophthalmol. 2017 Dec 1;135(12):1339-1344. doi: 10.1001/jamaophthalmol.2017.4508.
10
Mental health treatment associated with community-based depression screening: considerations for planning multidisciplinary collaborative care.心理健康治疗与社区为基础的抑郁筛查相关:规划多学科协作式护理的考虑因素。
Ann Pharmacother. 2013 Jun;47(6):797-804. doi: 10.1345/aph.1R730. Epub 2013 May 14.

引用本文的文献

1
Sleep Disorders and Fatigue among Patients with MS: The Role of Depression, Stress, and Anxiety.多发性硬化症患者的睡眠障碍与疲劳:抑郁、压力和焦虑的作用。
Neurol Res Int. 2024 Jan 29;2024:6776758. doi: 10.1155/2024/6776758. eCollection 2024.
2
Treating depression in clinical practice: new insights on the multidisciplinary use of trazodone.临床实践中抑郁症的治疗:曲唑酮多学科应用的新见解
Front Psychiatry. 2023 Aug 15;14:1207621. doi: 10.3389/fpsyt.2023.1207621. eCollection 2023.
3
Effects of N-acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis.N-乙酰半胱氨酸对多发性硬化症患者氧化应激生物标志物、抑郁和焦虑症状的影响。
Neuropsychopharmacol Rep. 2023 Sep;43(3):382-390. doi: 10.1002/npr2.12360. Epub 2023 Jun 30.
4
Evaluation of the Efficacy of Artificial Neural Network-Based Music Therapy for Depression.基于人工神经网络的音乐疗法治疗抑郁症的疗效评估。
Comput Intell Neurosci. 2022 Aug 21;2022:9208607. doi: 10.1155/2022/9208607. eCollection 2022.
5
Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study.伊朗克尔曼沙阿多发性硬化症患者的焦虑、抑郁和压力患病率:一项横断面研究。
BMC Psychiatry. 2020 Apr 15;20(1):166. doi: 10.1186/s12888-020-02579-z.
6
Microglial Phagocytosis of Neurons: Diminishing Neuronal Loss in Traumatic, Infectious, Inflammatory, and Autoimmune CNS Disorders.小胶质细胞对神经元的吞噬作用:减少创伤性、感染性、炎症性和自身免疫性中枢神经系统疾病中的神经元损失
Front Psychiatry. 2019 Oct 3;10:712. doi: 10.3389/fpsyt.2019.00712. eCollection 2019.
7
Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment.多发性硬化症中的抑郁:流行病学、病因学、诊断与治疗。
CNS Drugs. 2018 Feb;32(2):117-133. doi: 10.1007/s40263-018-0489-5.

本文引用的文献

1
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.对多发性硬化症合并症发病率和患病率的系统评价:概述。
Mult Scler. 2015 Mar;21(3):263-81. doi: 10.1177/1352458514564491. Epub 2015 Jan 26.
2
Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults.多重用药,包括增加跌倒风险的药物,以及社区居住的中老年人随后发生的跌倒。
Age Ageing. 2015 Jan;44(1):90-6. doi: 10.1093/ageing/afu141. Epub 2014 Oct 12.
3
Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.促进多发性硬化症患者对注射用疾病修正疗法的依从性。
Expert Rev Neurother. 2014 Sep;14(9):1029-42. doi: 10.1586/14737175.2014.945523. Epub 2014 Aug 11.
4
Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study.多发性硬化症患者的精神疾病诊断、药物治疗与残疾抚恤金风险:一项基于人群的登记研究
PLoS One. 2014 Aug 5;9(8):e104165. doi: 10.1371/journal.pone.0104165. eCollection 2014.
5
Depression screening in adolescents in the United States: a national study of ambulatory office-based practice.美国青少年抑郁症筛查:一项基于门诊办公室实践的全国性研究。
Acad Pediatr. 2014 Mar-Apr;14(2):186-91. doi: 10.1016/j.acap.2013.11.006.
6
Prevalence and predictors of depression in Iranian patients with multiple sclerosis: a population-based study.伊朗多发性硬化症患者抑郁的患病率及其预测因素:一项基于人群的研究。
Neurol Sci. 2014 May;35(5):735-40. doi: 10.1007/s10072-013-1593-4. Epub 2013 Dec 10.
7
The effect of fluoxetine on progression in progressive multiple sclerosis: a double-blind, randomized, placebo-controlled trial.氟西汀对进展型多发性硬化症病情进展的影响:一项双盲、随机、安慰剂对照试验。
ISRN Neurol. 2013 Jul 29;2013:370943. doi: 10.1155/2013/370943. eCollection 2013.
8
Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter study.度洛西汀治疗多发性硬化症患者的抑郁症有效:一项开放标签的多中心研究。
Clin Neuropharmacol. 2013 Jul-Aug;36(4):114-6. doi: 10.1097/WNF.0b013e3182996400.
9
Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.多发性硬化症中的抑郁症:成人及儿童群体评估与治疗方法综述
ISRN Neurol. 2012;2012:427102. doi: 10.5402/2012/427102. Epub 2012 Oct 14.
10
Stress, depression and antidepressant treatment options in patients suffering from multiple sclerosis.多发性硬化症患者的压力、抑郁和抗抑郁治疗选择。
Curr Pharm Des. 2012;18(36):5837-45. doi: 10.2174/138161212803523671.